JPS57163319A - Preparation of antibody - Google Patents

Preparation of antibody

Info

Publication number
JPS57163319A
JPS57163319A JP56047842A JP4784281A JPS57163319A JP S57163319 A JPS57163319 A JP S57163319A JP 56047842 A JP56047842 A JP 56047842A JP 4784281 A JP4784281 A JP 4784281A JP S57163319 A JPS57163319 A JP S57163319A
Authority
JP
Japan
Prior art keywords
human
interferon
antibody
peptide
carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56047842A
Other languages
Japanese (ja)
Other versions
JPH0243758B2 (en
Inventor
Fumio Shimizu
Yasukazu Omoto
Kenichi Imagawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Priority to JP56047842A priority Critical patent/JPS57163319A/en
Publication of JPS57163319A publication Critical patent/JPS57163319A/en
Publication of JPH0243758B2 publication Critical patent/JPH0243758B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PURPOSE: To collect a human β-interferon, by administering a human β-interferon antigen consisting of a composite of a N-terminated peptide with of a human β- interferon with a carrier to a mammal.
CONSTITUTION: An N-terminated peptide of a human β-interferon expressed by the formula (R is H, H-Phe-, H-Leu-Gly-Phe-, etc.) is reacted with a carrier in an amount of 2W6 times that of the peptide and a haptene-carrier linking reagent in a molar amount of 5W10 times that of the peptide in a buffer solution at a pH of 7W10 at 0W40°C to give a human β-interferon antigen, which is then administered to a mammal, e.g. a rabbit or guinea pig, to collect an antibody produced in the living body. The resultant antibody has improved specificity for the human β-interferon and high potency and sensitivity, and can be obtained at a high potency and sensitivity, and canb be obtained at a high reproducibility. The antibody can be reacted with a well-known insolubilizing substance to give an insolubilized antibody.
COPYRIGHT: (C)1982,JPO&Japio
JP56047842A 1981-03-31 1981-03-31 Preparation of antibody Granted JPS57163319A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP56047842A JPS57163319A (en) 1981-03-31 1981-03-31 Preparation of antibody

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56047842A JPS57163319A (en) 1981-03-31 1981-03-31 Preparation of antibody

Publications (2)

Publication Number Publication Date
JPS57163319A true JPS57163319A (en) 1982-10-07
JPH0243758B2 JPH0243758B2 (en) 1990-10-01

Family

ID=12786615

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56047842A Granted JPS57163319A (en) 1981-03-31 1981-03-31 Preparation of antibody

Country Status (1)

Country Link
JP (1) JPS57163319A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57122054A (en) * 1980-10-30 1982-07-29 Thomae Gmbh Dr K Tridecapeptide and manufacture

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57122054A (en) * 1980-10-30 1982-07-29 Thomae Gmbh Dr K Tridecapeptide and manufacture

Also Published As

Publication number Publication date
JPH0243758B2 (en) 1990-10-01

Similar Documents

Publication Publication Date Title
EP0253202A3 (en) Novel immunoconjugates and methods for their use in tumor therapy
AU629903B2 (en) Mitomycin c derivatized with a hapten
IL73437A (en) Method and test kit for detecting immune(clq)complexes in human serum by means of a mouse monoclonal antibody
EP0597829A4 (en) Novel monoclonal antibody to novel antigen associated with human tumors.
BE863810A (en) PROCESS FOR PREPARING AN ANTIGEN AND AN ANTIBODY
FI950062A (en) Foroactivation of proteins for conjugation purposes
EP0160250A3 (en) Monoclonal antibody panel for early diagnosis and therapy of renal carcinoma
EP0359063A3 (en) Antibody having high affinity to hapten as antigen and immunogen for obtaining the same
EP0284587A3 (en) Synthetic peptide antigens for the detection of hiv-1 infection
ATE69891T1 (en) MONOCLONAL ANTIBODY DRAFT FOR DIAGNOSTIC USE.
DE3379400D1 (en) Acetaminophen analogs, antigens, and antibodies
EP0311383A3 (en) Monoclonal antibody to methamphetamine, preparation of the same, assay method and assay kit of methamphetamine
JPS57163319A (en) Preparation of antibody
JPS5739350A (en) Preparation of toxoplasma antigen
ES8401261A1 (en) Procedure for immunological determinations using two antibodies, the second antibody being purified by affinity chromatography, and supports therefor.
JPS559120A (en) Method of measuring elastase-1 and measuring reagent set
JPS53124613A (en) Preparation of anti-ursodeoxycholic acid antibody, and detection reagent containing the same
EP0309992A3 (en) Iron colloid-labeled antibody, preparation thereof and histochemical detection thereby
GR3015489T3 (en) Monoclonal antibodies and process for the diagnosis of phytophtora infections.
JPS5616415A (en) Preparation of antibody
JPS6438658A (en) Solid phase antibody for immunoassay
BE858407A (en) ANTIGEN AND ANTIBODY DOSAGE PROCESS
JPS5386014A (en) Quantitative analysis of antigen and antibody
JPS6454356A (en) Method for suppressing non-specific adsorption of antibody to solid phase antigen
EP0273754A3 (en) Method of enhancing the biodistribution of antibody for localization in lesions